Pure Global

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure - Trial NCT03418753

Access comprehensive clinical trial information for NCT03418753 through Pure Global AI's free database. This phase not specified trial is sponsored by Oculogica, Inc. and is currently Completed. The study focuses on Intracranial Pressure Increase. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03418753
Completed
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT03418753
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

Study Focus

EyeBOX for ICP

Observational

diagnostic test

Sponsor & Location

Oculogica, Inc.

Baltimore,Rochester,Philadelphia, United States of America

Timeline & Enrollment

N/A

May 10, 2018

May 10, 2023

60 participants

Primary Outcome

Sensitivity and Specificity

Summary

The study is a prospective, multi-center, non-randomized, open label observational study. The
 objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of
 abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy
 catheter.

ICD-10 Classifications

Benign intracranial hypertension
Intracranial injury
Intracranial injury, unspecified
Other intracranial injuries
Intracranial hypotension following ventricular shunting

Data Source

ClinicalTrials.gov

NCT03418753

Non-Device Trial